User profiles for Simon J. Davis

Simon Davis

University of Oxford
Verified email at imm.ox.ac.uk
Cited by 20074

[PDF][PDF] The interaction properties of costimulatory molecules revisited

…, B Walse, DI Stuart, PA van der Merwe, SJ Davis - Immunity, 2002 - cell.com
B7-1 and B7-2 are generally thought to have comparable structures and affinities for their
receptors, CD28 and CTLA-4, each of which is assumed to be bivalent. We show instead (1) …

CD80 (B7-1) binds both CD28 and CTLA-4 with a low affinity and very fast kinetics

…, DL Bodian, S Daenke, P Linsley, SJ Davis - The Journal of …, 1997 - rupress.org
The structurally related T cell surface molecules CD28 and CTLA-4 interact with cell surface
ligands CD80 (B7-1) and CD86 (B7-2) on antigen-presenting cells (APC) and modulate T …

Molecular interactions mediating T cell antigen recognition

PA Merwe, SJ Davis - Annual review of immunology, 2003 - annualreviews.org
▪ Abstract Over the past decade, key protein interactions contributing to T cell antigen
recognition have been characterized in molecular detail. These have included interactions …

Crystal structure of the B7-1/CTLA-4 complex that inhibits human immune responses

…, DV Erbe, S Ikemizu, SJ Davis, ML Stahl, J Seehra… - Nature, 2001 - nature.com
Optimal immune responses require both an antigen-specific and a co-stimulatory signal. The
shared ligands B7-1 and B7-2 on antigen-presenting cells deliver the co-stimulatory signal …

The kinetic-segregation model: TCR triggering and beyond

SJ Davis, PA Van Der Merwe - Nature immunology, 2006 - nature.com
How the T cell receptor engages antigen is known, but not how that 'triggers' intracellular
signaling. The first direct support for a mechanism based on the spatial reorganization of …

The structure and ligand interactions of CD2: implications for T-cell function

SJ Davis, PA Van Der Merwe - Immunology today, 1996 - cell.com
The protein-protein interaction underlying l&and recogmtion by CD2 must ensure sprcifuty
while allowing for wry weak binding. The CD5Rbmdmg site on human CD2 has nuw brrn …

TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis

…, OA Leach, S Prömel, D Punwani, JH Felce, SJ Davis… - Nature, 2012 - nature.com
Although there has been much success in identifying genetic variants associated with
common diseases using genome-wide association studies (GWAS) 1 , it has been difficult to …

[HTML][HTML] The 2015 super-resolution microscopy roadmap

…, L Cognet, B Lounis, H Ewers, SJ Davis… - Journal of Physics D …, 2015 - iopscience.iop.org
Far-field optical microscopy using focused light is an important tool in a number of scientific
disciplines including chemical,(bio) physical and biomedical research, particularly with …

The immunological synapse and CD28-CD80 interactions

SK Bromley, A Iaboni, SJ Davis, A Whitty… - Nature …, 2001 - nature.com
According to the two-signal model of T cell activation, costimulatory molecules augment T
cell receptor (TCR) signaling, whereas adhesion molecules enhance TCR–MHC-peptide …

[HTML][HTML] Structure and interactions of the human programmed cell death 1 receptor

…, JE Ladbury, S Ikemizu, MD Carr, SJ Davis - Journal of Biological …, 2013 - ASBMB
PD-1, a receptor expressed by T cells, B cells, and monocytes, is a potent regulator of immune
responses and a promising therapeutic target. The structure and interactions of human PD…